Quick Answer
OptimizeRx Corp reported Net Income Loss of $5.13 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +125.5% in Net Income Loss from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$199.4 thousand | Q3 2014: -$294.5 thousand | Q1 2015: -$111.2 thousand | Q2 2015: -$157.2 thousand | Q3 2015: $87.9 thousand | Q1 2016: -$351.9 thousand | Q2 2016: -$591.9 thousand | Q3 2016: -$242.6 thousand | Q1 2017: -$882.7 thousand | Q2 2017: -$361.5 thousand | Q3 2017: -$622.8 thousand | Q1 2018: -$189.2 thousand | Q2 2018: $280.5 thousand | Q3 2018: $244.9 thousand | Q1 2019: $6.5 thousand | Q2 2019: $406.6 thousand | Q3 2019: -$1.57 million | Q1 2020: -$2.20 million | Q2 2020: -$1.08 million | Q3 2020: -$282.9 thousand | Q1 2021: -$637.4 thousand | Q2 2021: $352.1 thousand | Q3 2021: $39.9 thousand | Q1 2022: -$3.76 million | Q2 2022: -$3.88 million | Q3 2022: -$3.47 million | Q1 2023: -$6.40 million | Q2 2023: -$4.16 million | Q3 2023: -$2.87 million | Q1 2024: -$6.90 million | Q2 2024: -$4.01 million | Q3 2024: -$9.12 million | Q1 2025: -$2.20 million | Q2 2025: $1.53 million | Q3 2025: $779.0 thousand.
- Over the full 15 years of available data (2011 to 2025), OptimizeRx Corp's Net Income Loss has grown by 342.0%.
- Historical annual values: Fiscal year 2025: $5.13 million | Fiscal year 2024: -$20.11 million | Fiscal year 2023: -$17.57 million | Fiscal year 2022: -$11.44 million | Fiscal year 2021: $378.1 thousand | Fiscal year 2020: -$2.21 million | Fiscal year 2019: -$3.14 million | Fiscal year 2018: $226.3 thousand | Fiscal year 2017: -$2.10 million | Fiscal year 2016: -$1.54 million | Fiscal year 2015: -$595.1 thousand | Fiscal year 2014: -$1.03 million | Fiscal year 2013: -$267.3 thousand | Fiscal year 2012: -$454.6 thousand | Fiscal year 2011: -$2.12 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: